Third Quarter Earnings Call Scheduled for November 2, 2020 AUSTIN, Texas , Oct. 7, 2020 /PRNewswire/ --  Luminex Corporation (Nasdaq: LMNX) today announced 3 rd quarter 2020 revenues of approximately $106 million , up approximately 35% over the 3 rd quarter of 2019.

High-throughput diagnostic test will include most up-to-date respiratory pathogen targets AUSTIN, Texas , Sept. 24, 2020 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development Authority